Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
|
2
|
Zenith Epigenetics
|
Oct 08, 2024 01:00PM
|
Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
|
2
|
Zenith Epigenetics
|
Oct 08, 2024 09:45AM
|
Re: Just pathetic
|
1
|
Resverlogix Corp.
|
Sep 18, 2024 11:30PM
|
Re: Just pathetic
|
6
|
Resverlogix Corp.
|
Sep 16, 2024 08:14PM
|
Re: Your thoughts please
|
4
|
Resverlogix Corp.
|
Sep 09, 2024 04:56PM
|
Re: Your thoughts please
|
4
|
Resverlogix Corp.
|
Sep 09, 2024 03:08PM
|
Re: Your thoughts please
|
7
|
Resverlogix Corp.
|
Sep 08, 2024 02:00PM
|
Re: Your thoughts please
|
9
|
Resverlogix Corp.
|
Sep 07, 2024 10:34PM
|
Re: Apabetalone inhibits kidney damage in diabetes
|
7
|
Resverlogix Corp.
|
Aug 19, 2024 07:51PM
|
Market Cap - 10.5mil
|
5
|
Resverlogix Corp.
|
Jul 24, 2024 01:22PM
|
2024 Special Annual Meeting
|
6
|
Resverlogix Corp.
|
Jun 30, 2024 08:57PM
|
Re: A Special Meeting of Shareholders?
|
1
|
Resverlogix Corp.
|
May 30, 2024 09:07AM
|
Re: A Special Meeting of Shareholders?
|
|
Resverlogix Corp.
|
May 29, 2024 12:43PM
|
Re: A Special Meeting of Shareholders?
|
6
|
Resverlogix Corp.
|
May 28, 2024 11:33PM
|
A Special Meeting of Shareholders?
|
3
|
Resverlogix Corp.
|
May 28, 2024 08:57PM
|
Re: Notice of 2024 Annual Meeting Delayed?
|
2
|
Resverlogix Corp.
|
May 23, 2024 11:28AM
|
Notice of 2024 Annual Meeting Delayed?
|
2
|
Resverlogix Corp.
|
May 23, 2024 11:19AM
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
1
|
Zenith Epigenetics
|
May 20, 2024 11:26PM
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
2
|
Zenith Epigenetics
|
May 20, 2024 02:03PM
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
3
|
Zenith Epigenetics
|
May 19, 2024 10:21PM
|